SCHEMBL26323682

SCHEMBL26323682

O=Cc1c(Cl)[nH]c2cc(CO)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.46
CDK2 P24941 1/20 0.46
MAOA P21397 1/20 0.43
DYRK1A Q13627 1/20 0.43
PARP1 P09874 1/20 0.43
ALOX15 P16050 1/20 0.42
ERN1 O75460 1/20 0.40
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
FEN1 P39748 1/20 0.34
GSK3B P49841 1/20 0.34
RET P07949 1/20 0.33
KDR P35968 1/20 0.33
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26323678 0.88 MAPT (0.39) CDK1CDK2MAOADYRK1APARP1
SCHEMBL1144239 0.78 ALOX15 (0.54) PARP1ALOX15KDM4EALDH1A1AHR
SCHEMBL29878739 0.78 ALOX15 (0.54) PARP1ALOX15KDM4EALDH1A1AHR
SCHEMBL29952323 0.76 GSK3B (0.51) CDK1CDK2ALOX15ERN1GSK3B
SCHEMBL24522311 0.72 ALDH1A1 (0.57) CDK1CDK2MAOADYRK1AALOX15
SCHEMBL29362992 0.72 ALDH1A1 (0.57) CDK1CDK2MAOADYRK1AALOX15
SCHEMBL1093112 0.71 CDK1 (0.51) CDK1CDK2KDM4EALDH1A1GSK3B
SCHEMBL29953709 0.71 CDK1 (0.51) CDK1CDK2KDM4EALDH1A1GSK3B
SCHEMBL29956044 0.71 CA12 (0.41) CDK1ALOX15KDM4EALDH1A1GSK3B
SCHEMBL1626244 0.71 CA12 (0.41) CDK1ALOX15KDM4EALDH1A1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES RELA, NFKBIA, IKBKG CDK1 3530/4885CDK2 2342/4885MAOA 3605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.